| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.00061 | 1 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.00065 | 1 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.00065 | 1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.00051 | 1 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.00034 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.00034 | 1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.00026 | 1 |